Skip to content

Detection of Vascular Injury in Diabetes Through Eye and Nailfold Data (DIVIDEND) - A Pilot Study

Detection of Vascular Injury in Diabetes Through Eye and Nailfold Data (DIVIDEND) - A Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01279928
Acronym
DIVIDEND
Enrollment
26
Registered
2011-01-20
Start date
2010-03-31
Completion date
2010-10-31
Last updated
2011-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes Mellitus

Keywords

paediatric and adolescent population, nailfold capillaroscopy, laser Doppler flowmetry, retinal vessel calibre, retinal vessel fractal analysis, 24 hour Ambulatory Blood Pressure Monitoring

Brief summary

This project aimed to explore novel methods of detecting small blood vessel disease in a paediatric population with type 1 diabetes mellitus. To do this the techniques of Nailfold capillaroscopy, laser Doppler flowmetry, retinal (eye) vessel analysis and 24-hr Ambulatory Blood Pressure Monitoring were used. Each of these techniques investigated different areas of small blood vessels around the body. It was hypothesized that in a paediatric population with type 1 diabetes mellitus the novel investigations would be associated with small blood vessel disease and that widespread changes to these blood vessels would be detected through associations between the different novel investigations.

Interventions

PROCEDUREVideo Nailfold Capillaroscopy

Single session of video Nailfold Capillaroscopy wit KKK technology

DEVICEAmbulatory 24 hr Blood Pressure Monitoring

24 hr upper arm cuff measurement of Blood Pressure

PROCEDUREFundoscopy of eyes

examination of microvascular health of eye with the use of opthalmoscope

Examination of vascular flow

Sponsors

John Hunter Hospital
Lead SponsorOTHER_GOV

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
8 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* 8-18 years old * Have a diagnosis of type 1 diabetes mellitus

Exclusion criteria

* \< 8 years or \> 18 years old * Significant autoimmune rheumatological disease (e.g. lupus or dermatomyositis)

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026